TCL Archive NCI’s Chabner Cautions Against 3-Hour Taxol Infusion, May Lower Response Rate October 22, 1993
TCL Archive Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer March 26, 2010